You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Which of the following is effective in management of patients of hea failure with preserved ejection fraction? and explain in detail?
HFpEF (hea failure with preserved ejection fraction)- A.R.N.I (ARB & Nephrilysin inhibitor) HFrEF (hea failure with reduced ejection fraction)- ACE inhibitor+ Beta Blocker Phosphodiesterase inhibitor: RELAX trial- no improvement in functional capacity, quality of life (QOL), or other clinical and surrogate parameters in patients with HFpEF. Isosorbide mononitrate: (NEAT-HFpEF) trial- no improvement in QOL or submaximal exercise capacity in patients with HFpEF Digoxin Digitalis Investigation Group (DIG) found no role for digoxin in the treatment of HFpEF.